266 related articles for article (PubMed ID: 18248671)
1. NF-kappa B genes have a major role in inflammatory breast cancer.
Lerebours F; Vacher S; Andrieu C; Espie M; Marty M; Lidereau R; Bieche I
BMC Cancer; 2008 Feb; 8():41. PubMed ID: 18248671
[TBL] [Abstract][Full Text] [Related]
2. Nuclear factor-kappaB signature of inflammatory breast cancer by cDNA microarray validated by quantitative real-time reverse transcription-PCR, immunohistochemistry, and nuclear factor-kappaB DNA-binding.
Van Laere SJ; Van der Auwera I; Van den Eynden GG; Elst HJ; Weyler J; Harris AL; van Dam P; Van Marck EA; Vermeulen PB; Dirix LY
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3249-56. PubMed ID: 16740744
[TBL] [Abstract][Full Text] [Related]
3. Similar NF-κB gene signatures in TNF-α treated human endothelial cells and breast tumor biopsies.
Perrot-Applanat M; Vacher S; Toullec A; Pelaez I; Velasco G; Cormier F; Saad Hel S; Lidereau R; Baud V; Bièche I
PLoS One; 2011; 6(7):e21589. PubMed ID: 21754991
[TBL] [Abstract][Full Text] [Related]
4. NF-kappaB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivation.
Van Laere SJ; Van der Auwera I; Van den Eynden GG; van Dam P; Van Marck EA; Vermeulen PB; Dirix LY
Br J Cancer; 2007 Sep; 97(5):659-69. PubMed ID: 17700572
[TBL] [Abstract][Full Text] [Related]
5. Intermittent hypoxia confers pro-metastatic gene expression selectively through NF-κB in inflammatory breast cancer cells.
Gutsche K; Randi EB; Blank V; Fink D; Wenger RH; Leo C; Scholz CC
Free Radic Biol Med; 2016 Dec; 101():129-142. PubMed ID: 27717868
[TBL] [Abstract][Full Text] [Related]
6. Aberrant activation of NF-κB signaling in mammary epithelium leads to abnormal growth and ductal carcinoma in situ.
Barham W; Chen L; Tikhomirov O; Onishko H; Gleaves L; Stricker TP; Blackwell TS; Yull FE
BMC Cancer; 2015 Sep; 15():647. PubMed ID: 26424146
[TBL] [Abstract][Full Text] [Related]
7. Distinct molecular signature of inflammatory breast cancer by cDNA microarray analysis.
Van Laere S; Van der Auwera I; Van den Eynden GG; Fox SB; Bianchi F; Harris AL; van Dam P; Van Marck EA; Vermeulen PB; Dirix LY
Breast Cancer Res Treat; 2005 Oct; 93(3):237-46. PubMed ID: 16172796
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.
Van den Eynden GG; Van Laere SJ; Van der Auwera I; Merajver SD; Van Marck EA; van Dam P; Vermeulen PB; Dirix LY; van Golen KL
Breast Cancer Res Treat; 2006 Feb; 95(3):219-28. PubMed ID: 16244790
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory cytokine-enriched microenvironment plays key roles in the development of breast cancers.
Takeuchi Y; Gotoh N
Cancer Sci; 2023 May; 114(5):1792-1799. PubMed ID: 36704829
[TBL] [Abstract][Full Text] [Related]
10. Human cytomegalovirus infection enhances NF-κB/p65 signaling in inflammatory breast cancer patients.
El-Shinawi M; Mohamed HT; El-Ghonaimy EA; Tantawy M; Younis A; Schneider RJ; Mohamed MM
PLoS One; 2013; 8(2):e55755. PubMed ID: 23418456
[TBL] [Abstract][Full Text] [Related]
11. Markers of subtypes in inflammatory breast cancer studied by immunohistochemistry: prominent expression of P-cadherin.
Ben Hamida A; Labidi IS; Mrad K; Charafe-Jauffret E; Ben Arab S; Esterni B; Xerri L; Viens P; Bertucci F; Birnbaum D; Jacquemier J
BMC Cancer; 2008 Jan; 8():28. PubMed ID: 18230143
[TBL] [Abstract][Full Text] [Related]
12. Molecular profiling of inflammatory breast cancer: identification of a poor-prognosis gene expression signature.
Bièche I; Lerebours F; Tozlu S; Espie M; Marty M; Lidereau R
Clin Cancer Res; 2004 Oct; 10(20):6789-95. PubMed ID: 15501955
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of PIMREG promotes breast cancer aggressiveness via constitutive activation of NF-κB signaling.
Jiang L; Ren L; Zhang X; Chen H; Chen X; Lin C; Wang L; Hou N; Pan J; Zhou Z; Huang H; Huang D; Yang J; Liang Y; Li J
EBioMedicine; 2019 May; 43():188-200. PubMed ID: 30979686
[TBL] [Abstract][Full Text] [Related]
14. Correlated expression of Fas, NF-kappaB, and VEGF-C in infiltrating ductal carcinoma of the breast.
Dai XL; Zhou SL; Qiu J; Liu YF; Hua H
Eur J Gynaecol Oncol; 2012; 33(6):633-9. PubMed ID: 23327061
[TBL] [Abstract][Full Text] [Related]
15. Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC.
Iwase T; Harano K; Masuda H; Kida K; Hess KR; Wang Y; Dirix L; Van Laere SJ; Lucci A; Krishnamurthy S; Woodward WA; Layman RM; Bertucci F; Ueno NT
BMC Cancer; 2020 May; 20(1):430. PubMed ID: 32423453
[TBL] [Abstract][Full Text] [Related]
16. [Activation and prognostic significance of AKT, NF-kappaB and STAT3 in breast cancer with lymph node metastasis and estrogen receptor expression].
Liu C; Zhou S; Ke CS; Li NP; Wu RL
Ai Zheng; 2007 Sep; 26(9):929-36. PubMed ID: 17927847
[TBL] [Abstract][Full Text] [Related]
17. A20, an essential component of the ubiquitin-editing protein complex, is a negative regulator of inflammation in human myometrium and foetal membranes.
Lappas M
Mol Hum Reprod; 2017 Sep; 23(9):628-645. PubMed ID: 28911210
[TBL] [Abstract][Full Text] [Related]
18. TRIM44 Is a Poor Prognostic Factor for Breast Cancer Patients as a Modulator of NF-κB Signaling.
Kawabata H; Azuma K; Ikeda K; Sugitani I; Kinowaki K; Fujii T; Osaki A; Saeki T; Horie-Inoue K; Inoue S
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885545
[TBL] [Abstract][Full Text] [Related]
19. PIK3CA mutations in ductal carcinoma in situ and adjacent invasive breast cancer.
Agahozo MC; Sieuwerts AM; Doebar SC; Verhoef EI; Beaufort CM; Ruigrok-Ritstier K; de Weerd V; Sleddens HFBM; Dinjens WNM; Martens JWM; van Deurzen CHM
Endocr Relat Cancer; 2019 May; 26(5):471-482. PubMed ID: 30844755
[TBL] [Abstract][Full Text] [Related]
20. Profiling differential microRNA expression between in situ, infiltrative and lympho-vascular space invasive breast cancer: a pilot study.
Soon PS; Provan PJ; Kim E; Pathmanathan N; Graham D; Clarke CL; Balleine RL
Clin Exp Metastasis; 2018 Feb; 35(1-2):3-13. PubMed ID: 29214365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
